Gruppo Oncologico Italiano Di Ricerca Clinica

This study is for people with a specific type of lung cancer (EGFR-mutated NSCLC) who have had surgery and then took the drug osimertinib to prevent the cancer from coming back. Even with this treatment, the cancer sometimes returns. The study aims to understand why by looking at…

This study is observing people with advanced non-small cell lung cancer (NSCLC) in Italy to find out how common HER2 mutations are and how doctors currently treat them. About 50 participants will be followed for one year. The goal is to gather real-world information, not to test …